Novogenia AG (MUN:7V0)
Germany · Delayed Price · Currency is EUR 5.80
-0.70 (-10.77%)
At close: Aug 19, 2026
Novogenia AG Revenue
In the year 2025, Novogenia AG had annual revenue of 54.30M EUR with 98.53% growth. Novogenia AG had revenue of 12.94M in the quarter ending December 31, 2025.
Revenue
54.30M
Revenue Growth
+98.53%
P/S Ratio
1.28
Revenue / Employee
266.20K
Employees
204
Market Cap
69.60M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 54.30M | 26.95M | 98.53% |
| Dec 31, 2024 | 27.35M | 9.18M | 50.55% |
| Dec 31, 2023 | 18.17M | -192.17M | -91.36% |
| Dec 31, 2022 | 210.34M | 77.27M | 58.07% |
| Dec 31, 2021 | 133.07M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Biotest GmbH & Co. KGaA | 648.90M |
| Paion AG | 14.81M |
| MagForce AG | 1.08M |
| Biomark Diagnostics | 37.15K |
| co.don AG | 22.00K |
| bioXXmed AG | 16.73K |
| 2invest AG | -1.64M |